Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Recommendations

Info

CONFERENCE ORGANIZERS Conference Organizers Conference Chairs Galit Alter Harvard University Center for AIDS Research Ragon Institute of MGH, MIT and Harvard Harvard Medical School, Massachusetts General Hospital, USA Conference Co-Chairs Lindsey Baden Harvard University Center for AIDS Research Brigham and Women’s Hospital Ragon Institute of MGH, MIT, and Harvard, USA Local Organizing Committee Marylyn Addo Ragon Institute of MGH, MIT and Harvard, USA Anna Aldovini Children’s Hospital Boston and Harvard Medical School, USA Marcus Altfeld Ragon Institute of MGH, MIT and Harvard, USA Amit Dixit Boston LGBT Film Festival, USA Max Essex Harvard School of Public Health and Botswana Harvard AIDS Institute Partnership, USA Henry Hoey Intersystems, USA Darrell Irvine Massachusetts Institute of Technology, Ragon Institute of MGH, MIT and Harvard, and Howard Hughes Medical Institute at Harvard University, USA Paul Johnson Harvard Medical School and Massachusetts General Hospital, USA Scientific Organizing Committee Galit Alter Harvard Medical School, Massachusetts General Hospital, USA Lindsey Baden Brigham and Women’s Hospital, USA Susan Barnett Novartis Vaccines and Diagnostics, Inc., USA Dan Barouch Harvard Medical School, Beth Israel Deaconess Medical Center, USA Christian Brander IrsiCaixa AIDS Research Institute–HIVACAT, Spain Susan Buchbinder San Francisco Department of Public Health, USA Wendy Burgers University of Cape Town, South Africa Jacques Fellay Federal Institute of Technology, Switzerland ii AIDS Vaccine 2012 Dan Barouch Harvard University Center for AIDS Research Beth Israel Deaconess Medical Center Ragon Institute of MGH, MIT, and Harvard, USA Bruce Walker Harvard University Center for AIDS Research Ragon Institute of MGH, MIT and Harvard Harvard Medical School, Howard Hughes Medical Institute, USA Jeremy Luban University of Massachusetts Medical School, USA Bob Massie Initiative for Responsible Investment at Harvard University, USA Kenneth Mayer Fenway Health/Beth Israel Deaconess Medical Center, USA Silke Paust Harvard Medical School, Department of Microbiology and Immunobiology, USA Bharat Ramratnam COBRE Center for Cancer Research, Division of Infectious Diseases, Alpert Medical School of Brown University, USA Ruth Ruprecht Dana-Farber Cancer Institute, Harvard Medical School, USA Joseph Sodroski Dana-Farber Cancer Institute, Harvard Medical School, USA Nicole Frahm Fred Hutchinson Cancer Research Center, USA Glenda Gray Perinatal HIV Research Unit, South Africa Catherine Hankins Amsterdam Institute for Global Health and Development, Netherlands Barton Haynes Duke Human Vaccine Institute, Duke University, USA Peggy Johnston Bill & Melinda Gates Foundation, USA Gunilla Karlsson-Hedestam Karolinska Institutet, Sweden Jerome Kim U.S. Military HIV Research Program, USA Wayne Koff International AIDS Vaccine Initiative, USA
Scientific Organizing Committee (cont.) Michelle Lally Lifespan and Alpert Medical School of Brown University, USA Shan Lu University of Massachussets Medical School, USA Amapola Manrique Global HIV Vaccine Enterprise, USA John Mascola Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA Bonnie Mathieson Office of AIDS Research, National Institutes of Health, USA Penny Moore Centre for HIV and STIs, National Institute for Communicable Diseases, South Africa Thumbi N’dung’u HIV Pathogenesis Programme, University of KwaZulu-Natal, South Africa Steering Group William Snow (Chair) Global HIV Vaccine Enterprise, USA Galit Alter Harvard Medical School, Massachusetts General Hospital, USA Dan Barouch Harvard Medical School, Beth Israel Deaconess Medical Center, USA Bonaventura Clotet IrsiCaixa AIDS Research Institute–HIVACAT, Spain José Esparza Bill & Melinda Gates Foundation, USA José Gatell Hospital Clínic-IDIBAPS, Spain Catherine Hankins Amsterdam Institute for Global Health and Development, Netherlands Barton Haynes Duke Human Vaccine Institute, Duke University, USA Pontiano Kaleebu Uganda Virus Research Institute, Uganda Conference Organizers Giuseppe Pantaleo Centre Hospitalier Universitaire Vaudois, Switzerland Morgane Rolland U.S. Military HIV Research Program/Henry M. Jackson Foundation, USA Jeffrey Safrit Elizabeth Glaser Pediatric AIDS Foundation, USA Yiming Shao Chinese Center for Disease Control and Prevention, China Steve Wakefield HIV Vaccine Trials Network, USA Bruce Walker Ragon Institute of MGH, MIT and Harvard, USA Mitchell Warren AVAC, USA Yves Lévy Centre Hospitalier Universitaire Henri-Mondor, France Siobhan Malone Bill & Melinda Gates Foundation, USA Bonnie Mathieson National Institutes of Health, Office of AIDS Research, USA Margaret McCluskey United States Agency for International Development, USA Howard Njoo Public Health Agency of Canada, Canada Punnee Pitisuttithum Faculty of Tropical Medicine, Mahidol University, Thailand Rino Rappuoli Novartis, Italy Steve Wakefield HIV Vaccine Trials Network, USA Review Committee In addition to the Local Organizing Committee and the Scientific Organizing Committee, AIDS Vaccine 2012 thanks the following individuals for reviewing abstracts. Alash’le G. Abimiku Institute of Human Virology, University of Maryland School of Medicine, USA Todd Allen Ragon Institute of MGH, MIT and Harvard, USA John Altman Emory University, USA Rama Rao Amara Emory University, USA Victor Appay INSERM, Université Pierre et Marie Curie, Pitié-Salpêtrière Hospital, France Deborah Birx Centers for Disease Control and Prevention, USA Luigi Buonaguro National Cancer Institute “G. Pascale” Foundation, Italy Robert Chen Centers for Disease Control and Prevention, USA AIDS Vaccine 2012 iii CONFERENCE ORGANIZERS
Page 2 and 3: AIDS Vaccine 2012 PROGRAM AT A GLAN
Page 4 and 5: AIDS Vaccine 2012 Partners www.alli
Page 8 and 9: CONFERENCE ORGANIZERS Conference Or
Page 10 and 11: SCHOLARSHIP RECIPIENTS Awards and S
Page 12 and 13: SCHOLARSHIP RECIPIENTS Awards and S
Page 14 and 15: PROGRAM / MONDAY 2 Program Monday,
Page 16 and 17: PROGRAM / MONDAY 4 Program 11:00 -
Page 22 and 23: PROGRAM / TUESDAY 10 Program Tuesda
Page 24 and 25: PROGRAM / TUESDAY 12 Program 11:45
Page 26 and 27: PROGRAM / TUESDAY 14 Program 13:30
Page 28 and 29: PROGRAM / TUESDAY 16 Program Poster
Page 30 and 31: PROGRAM / TUESDAY 18 Program AIDS V
Page 32 and 33: PROGRAM / WEDNESDAY 20 Program Wedn
Page 34 and 35: 22 AIDS Vaccine 2012
Page 36 and 37: PLENARY SESSIONS 24 Plenary Session
Page 42 and 43: SYMPOSIA SESSIONS 30 Symposia Sessi
Page 56 and 57:
SYMPOSIA SESSIONS 44 Symposia Sessi
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
ORAL ABSTRACT SESSIONS 54 Oral Abst
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
92 AIDS Vaccine 2012
Page 106 and 107:
POSTERS 94 AIDS Vaccine 2012
Page 108 and 109:
POSTERS 96 Posters Topic 1: Adjuvan
Page 110 and 111:
POSTERS 98 Posters Topic 1: Adjuvan
Page 112 and 113:
POSTERS Posters Topic 1: Adjuvants,
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
POSTERS Posters Topic 2: Animal Mod
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
POSTERS Posters Topic 3: B Cell Imm
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
POSTERS Posters Topic 4: Clinical V
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
POSTERS Posters Topic 5: HIV Transm
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
POSTERS Posters Topic 6: Immunogene
Page 192 and 193:
POSTERS Posters Topic 7: Innate Imm
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
POSTERS Posters Topic 8: Mucosal Im
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
POSTERS Posters Topic 9: Non-Vaccin
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
POSTERS Posters Topic 10: Social/Et
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
POSTERS Posters Topic 11: T Cell Im
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
POSTERS Posters Topic 12: Vaccine C
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
POSTERS Posters Topic 13: Pediatric
Page 290 and 291:
AUTHOR INDEX Author Index Brander,
Page 292 and 293:
AUTHOR INDEX Author Index Guan, Y .
Page 294 and 295:
AUTHOR INDEX Author Index Lucas, J.
Page 296 and 297:
AUTHOR INDEX Author Index Quinn, T
Page 298 and 299:
AUTHOR INDEX Author Index Wendel-Ha
Page 300 and 301:
Notes 288
Page 302 and 303:
Notes 290
Page 305:
Poster Session 1 - Monday, 10 Septe
show all

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Create successful ePaper yourself

Delete template?

Save as template?